CEBPG suppresses ferroptosis through transcriptional control of SLC7A11 in ovarian cancer
Abstract Background Ovarian cancer (OC) has high mortality and poor prognosis for lacking of specific biomarkers and typical clinical symptoms in the early stage. CEBPG is an important regulator in tumor development, yet it is unclear exactly how it contributes to the progression of OC. Methods TCGA...
Main Authors: | Xiaoqian Zhang, Xiaocui Zheng, Xiang Ying, Weiwei Xie, Yujia Yin, Xipeng Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-023-04136-0 |
Similar Items
-
Natural Product Auraptene Targets SLC7A11 for Degradation and Induces Hepatocellular Carcinoma Ferroptosis
by: Donglin Li, et al.
Published: (2024-08-01) -
MiR-93-5p inhibits ovarian cancer through SLC7A11-mediated-ferroptosis
by: Chunxia Li, et al.
Published: (2024-08-01) -
SLC7A11 as a Gateway of Metabolic Perturbation and Ferroptosis Vulnerability in Cancer
by: Jaewang Lee, et al.
Published: (2022-12-01) -
High glucose induces podocyte ferroptosis through BAP1/SLC7A11 pathway
by: Ren Peiyao, et al.
Published: (2025-01-01) -
SPTBN2 suppresses ferroptosis in NSCLC cells by facilitating SLC7A11 membrane trafficking and localization
by: Jun Deng, et al.
Published: (2024-04-01)